Duke Alumnus Receives Marshall Scholarship for Graduate Study in the United Kingdom
A Duke alumnus is among the 49 recipients of the prestigious Marshall Scholarship, the program announced Monday.
Logan Glasstetter, from Davison, Michigan, received the Marshall to support his scientific research and scholarship. His research interests represent a broad range of disciplines: chemistry, nanoparticle therapy, regenerative medicine, and drug discovery pertaining to protein-misfolding diseases.
Marshall Scholarships are awarded each year to high-achieving American students to pursue post-graduate studies from all academic disciplines at any university in the United Kingdom. The award covers all university fees, cost-of-living expenses, and many other expenditures.
Glastetter’s research activities have spanned three institutions: Duke University, the Mayo Clinic and the National Institutes of Health. Glasstetter graduated in December 2022 with a double major in chemistry and biology. While at Duke, he received the 2021 Duke Faculty Scholar Award, the highest honor bestowed by Duke faculty celebrating undergraduate research and academic achievement.
Currently at the National Institutes of Health, Glasstetter is working to discover new small-
molecule therapeutics for two protein-misfolding diseases: Parkinson’s disease, a common neurodegenerative disease, and Gaucher disease, a rare lysosomal storage disorder.
“Logan is an exceptional student and scientist who distinguished himself through his undergraduate research in two Duke faculty labs, and is motivated to pursue a career in medical science for the benefit of others,” said Duke President Vincent E. Price. “I am delighted he has been selected as a Marshall Scholar and will have the opportunity to continue his studies in the United Kingdom.”
As a Marshall Scholar, Glasstetter will pursue a master’s degree in drug discovery and development at the University of Leeds and a master’s in chemistry at the University of Cambridge.
He plans to become a physician-scientist in the field of drug discovery and development, producing novel therapies for difficult-to-treat protein-misfolding diseases. In the UK, he plans to study these diseases, which include Parkinson’s disease, Alzheimer’s disease, and Type 2 diabetes, by training under internationally renowned experts focusing on structure-based drug discovery.
Duke students and alumni can receive support for opportunities like the Marshall Scholarship from the Nationally Competitive Scholarships team at the Office of University Scholars and Fellows.